A Study of GB261 in Systemic Sclerosis

A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis

NCT07321093 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis

NCT05265728 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis

NCT00468611 ·Status: TERMINATED ·Phase: PHASE3

A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)

NCT02453256 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis

NCT00087529 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis

NCT01416155 ·Status: COMPLETED ·Phase: PHASE2

Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis

NCT04261790 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

NCT07225504 ·Status: RECRUITING ·Phase: PHASE3

Safety of Bryostatin in Patients With MS

NCT06190912 ·Status: TERMINATED ·Phase: PHASE1

A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668

NCT02313285 ·Status: COMPLETED

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

NCT05441488 ·Status: SUSPENDED ·Phase: PHASE3

This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis

NCT07303790 ·Status: RECRUITING ·Phase: EARLY_PHASE1

The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis

NCT06599307 ·Status: RECRUITING ·Phase: PHASE2

A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis

NCT02977533 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Mitoxantrone in Multiple Sclerosis

NCT00146159 ·Status: TERMINATED ·Phase: PHASE3

First-in-Human Study With GNbAC1 in Healthy Volunteers

NCT01699555 ·Status: COMPLETED ·Phase: PHASE1

The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis

NCT00917839 ·Status: UNKNOWN ·Phase: PHASE2

Dose Escalation Study to Evaluate the Penetration and Pharmacodynamic Effects of Baminercept in the Cerebrospinal Fluid (CSF)and Safety in Subjects With Secondary Progressive Multiple Sclerosis (SPMS)

NCT01181089 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

NCT07299019 ·Status: RECRUITING ·Phase: PHASE3

Oral Guanabenz for Multiple Sclerosis

NCT02423083 ·Status: TERMINATED ·Phase: PHASE1

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis

NCT03798366 ·Status: COMPLETED ·Phase: PHASE2

A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis

NCT02576717 ·Status: COMPLETED ·Phase: PHASE3

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

NCT01665144 ·Status: COMPLETED ·Phase: PHASE3

Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)

NCT02688985 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis

NCT06210945 ·Status: SUSPENDED ·Phase: PHASE2